Home Study Details

Home / Learn / Home Study CE / Home Study Details

New Treatment Options for T2D - A Focus on Glycemic Control and Lowering CV Risk

Program Type

OnDemand

Credits

2 Contact Hour(s)

Release Date

Tuesday, August 13, 2019

Offline Date:

Friday, August 13, 2021

ACPE Expiration Date

Sunday, February 13, 2022

Target Audience

Nurse, Pharmacist, Pharmacy Technician

Cost

$8.00

PAY & BEGIN

Pay & proceed to the CE materials and test. You have unlimited test attempts and must score a 70% or better to earn CE credit.

BEST VALUE:

Members pay once for a year of unlimited CE!

ActivityINFORMATION

Overview

Patients with diabetes are also much more likely to suffer from cardiovascular disease than those without diabetes. In fact, cardiovascular disease is the leading cause of death associated with diabetes – certainly a medical double jeopardy. The American Diabetes Association’s (ADA) recently published the 2017 Standards of Medical Care in Diabetes and included new recommendations on treating both diabetes and cardiovascular disease. Pharmacists are often the medical professional that patients reach out to for guidance and explanation on new pharmaco-therapy and individualized treatment. This program will review the ADA’s latest update to the Standards of Medical Care in Diabetes, review recent outcomes trials of antihyperglycemic therapies in patients with type 2 diabetes (T2D) and outline evidence based treatment strategies to mitigate the risk of cardiovascular disease in patients with T2D.

Identify guidelines that are recommended by the ADA and AACE for CV risk reduction and the others in this class

Pharmacy Technician

Review how different treatment options work to lower blood sugar levels in patients with diabetes

List some common safety concerns about different agents used to treat type 2 diabetes

ActivityACCREDITATION

Activity Type

Knowledge

Universal Activity Number

Nurse0798-0000-18-265-H01-N

Pharmacist0798-0000-18-265-H01-P

Pharmacy Technician0798-0000-18-265-H01-T

PharmCon, Inc. is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.

PharmCon, Inc. is an approved course provider for continuing education for nurses by the Florida Board of Nursing. PharmCon is also recognized by the California Board of Nursing as a provider of nursing programs.

In order to obtain a Statement of Credit, participants must score no less than a 70% on the activity's test and complete a program evaluation.

This continuing education activity is held as copyright by PharmCon, Inc. Through this notice, PharmCon, Inc. grants permission of its use for educational purposes only. These materials may not be used, in whole or in part, for any commercial purposes without prior permission in writing from the copyright owner(s).